Latham Advises DHL Group on the Acquisition of CRYOPDP

Latham & Watkins had advised DHL Group, the world's leading logistics provider, on its acquisition of CRYOPDP, a leading specialty courier focused on clinical trials, biopharma, and cell and gene therapies, from Cryoport, a global provider of supply chain solutions for the life sciences sector.

In conjunction with this acquisition, DHL and Cryoport also announced a strategic partnership to strengthen their supply chain service offerings for the global life sciences and healthcare sector.

The transaction and the outlined partnership are subject to regulatory approvals.

Latham & Watkins represents DHL Group in the acquisition with a French corporate deal team led by Paris partner Pierre-Louis Cléro, with associates Morgane Chaloin, Armand Levivier, and Cheryl Yviquel; and a US corporate deal team led by Orange County partner Charles Ruck, and Chicago partner Sean Parish, with associates Katie Connelly and Eugenio Ascanio Carrera. Advice was also provided on healthcare and life sciences regulatory matters by Washington, D.C. partners Jason Caron and Ben Haas, Frankfurt partner Deniz Tschammler, and Washington, D.C. counsel Monica Groat; on French tax matters by Paris partner Olivia Rauch-Ravisé, with associate Hugo Matricon; on US tax matters by Chicago partner Enrique Rene de Vera, with associate Valerie Silva Parra; on German tax matters by Hamburg partner Verena Seevers, with associate Manuela Minsel; on IP and commercial contracts matters by Paris partner Jean-Luc Juhan, with associates Daniel Martel and Jean Bergeron; on global antitrust matters by Paris partner Mathilde Saltiel, with associate Louis-Victor Sachs; on UK antitrust matters by London partner Greg Bonné, with associate Panya Baldia; on French FDI matters by Paris partner Charles-Antoine Guelluy, with associate Alexandre de Puysegur; and on French employee matters by Paris partner Matthias Rubner, with associate Yanis Gaoua.